VDR and cancer: A meta-analysis that included 44,165 Caucasian patients (from the United Kingdom), from 64 studies, diagnosed with cancer, associated the mutated genotypes VDR rs1544410 (BsmI)-TT and CT with lower patient survival compared to the wild-type VDR rs1544410 (BsmI)-CC genotype (p < 0.050, HR=1.40, 95% CI = 1.05–1.75, I2 = 0.85; TT/CT vs. CC) [14].